Table3_通过WGCNA和机器学习方法识别胆道闭锁诊断生物标志物和潜在治疗靶点

包含胆道闭锁WGCNA和机器学习分析结果,提供差异表达基因及诊断生物标志物CXCL8和TMSB10的表格数据。

NIAID Data Ecosystem
浏览 29
表格biliary atresiabioinformaticsmachine learningtherapeutic targetsbiomarkers
Table3_Identification of diagnostic biomarkers and potential therapeutic targets for biliary atresia via WGCNA and machine learning methods.xls

基本信息

模态
表格
大小
0.001145856 GB
许可
CC BY 4.0
创建/更新时间
2026-10-08
版本
v1

资源简介

Table3_通过WGCNA和机器学习方法识别胆道闭锁诊断生物标志物和潜在治疗靶点

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 1.15 MB,主题涵盖 biliary atresia、bioinformatics、machine learning、therapeutic targets、biomarkers,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Table3_Identification of diagnostic biomarkers and potential therapeutic targets for biliary atresia via WGCNA and machine learning methods.xls》。配套论文《Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century》发表于 Hepatology(2018),DOI:10.1002/hep.29905。源站首次发布:2024-06-26。

【数据内容】

源站原始描述:Biliary atresia (BA) is a severe and progressive biliary obstructive disease in infants that requires early diagnosis and new therapeutic targets. This study employed bioinformatics methods to identify diagnostic biomarkers and potential therapeutic targets for BA. Our analysis of mRNA expression from Gene Expression Omnibus datasets revealed 3,273 differentially expressed genes between patients with BA and those without BA (nBA). Weighted gene coexpression network analysis determined that the t…

【数据结构与技术规格】

文件数 1 个,合计 1.15 MB。Table3_Identification of diagnostic biomarkers and potential therapeutic targets for biliary atresia via WGCNA and machine learning methods.xls:application/vnd.ms-excel,1.15 MB。数据集 DOI:10.3389/fped.2024.1339925.s004。

【主题与分类】

源站学科分类:Foetal Development and Medicine、Obstetrics and Gynaecology、Paediatrics、Paediatrics and Reproductive Medicine not elsewhere classified。主题标签:biliary atresia、bioinformatics、machine learning、therapeutic targets、biomarkers。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Table3_Identification_of_diagnostic_biomarkers_and_potential_therapeutic_targets_for_biliary_atresia_via_WGCNA_and_machine_learning_methods_xls/26104426

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Xu, Lei; Xiao, Ting; Zou, Biao; Rong, Zhihui; Yao, Wei (2024). Table3_Identification of diagnostic biomarkers and potential therapeutic targets for biliary atresia via WGCNA and machine learning methods.xls. Frontiers. Dataset

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table3_Identification of diagnostic biomarkers and potential therapeutic targets for biliary atresia via WGCNA and machine learning methods.xls" "https://ndownloader.figshare.com/files/47247265"

文件清单

  • Table3_Identification of diagnostic biomarkers and potential therapeutic targets for biliary atresia via WGCNA and machine learning methods.xls(1.15 MB)

文件总体积 1.15 MB(源站 API 实测)。

数据说明

Biliary atresia (BA) is a severe and progressive biliary obstructive disease in infants that requires early diagnosis and new therapeutic targets. This study employed bioinformatics methods to identify diagnostic biomarkers and potential therapeutic targets for BA. Our analysis of mRNA expression from Gene Expression Omnibus datasets revealed 3,273 differentially expressed genes between patients with BA and those without BA (nBA). Weighted gene coexpression network analysis determined that the turquoise gene coexpression module, consisting of 298 genes, is predominantly associated with BA. The machine learning method then filtered out the top 2 important genes, CXCL8 and TMSB10, from the turquoise module. The area under receiver operating characteristic curves for TMSB10 and CXCL8 were 0.961 and 0.927 in the training group and 0.819 and 0.791 in the testing group, which indicated a high diagnostic value. Besides, combining TMSB10 and CXCL8, a nomogram with better diagnostic performance was built for clinical translation. Several studies have highlighted the potential of CXCL8 as a therapeutic target for BA, while TMSB10 has been shown to regulate cell polarity, which was related to BA progression. Our analysis with qRT PCR and immunohistochemistry also confirmed the upregulation of TMSB10 at mRNA and protein levels in BA liver samples. These findings highlight the sensitivity of CXCL8 and TMSB10 as diagnostic biomarkers and their potential as therapeutic targets for BA.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fped.2024.1339925.s004(source: https://frontiersin.figshare.com/articles/dataset/Table3_Identification_of_diagnostic_biomarkers_and_potential_therapeutic_targets_for_biliary_atresia_via_WGCNA_and_machine_learning_methods_xls/26104426)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案